Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Stockholders Equity (Unaudited)

v3.26.1
Consolidated Statements of Stockholders Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Balance, shares at Dec. 31, 2024   189      
Balance, amount at Dec. 31, 2024 $ 2,857 $ 0 $ 53,195 $ (50,136) $ (202)
Stock based compensation 192 0 192 0 0
Net loss for the period (2,372) 0 0 (2,372) 0
Other comprehensive loss (25) $ 0 0 0 (25)
Balance, shares at Mar. 31, 2025   189      
Balance, amount at Mar. 31, 2025 652 $ 0 53,387 (52,508) (227)
Balance, shares at Dec. 31, 2025   673      
Balance, amount at Dec. 31, 2025 (1,272) $ 1 62,014 (63,015) (272)
Stock based compensation 256 0 256 0 0
Net loss for the period (2,958) 0 0 (2,958) 0
Other comprehensive loss 26 $ 0 0 0 26
Reverse split adjustment, shares   28      
Reverse split adjustment, amount 0 $ 0 0 0 0
Common shares issued as a fee in equity purchase agreement, shares   35      
Common shares issued as a fee in equity purchase agreement, amount 145 $ 0 145 0 0
Common shares issued for cash, net of issuance costs, shares   81      
Common shares issued for cash, net of issuance costs, amount 10,033 $ 0 10,033 0 0
Warrants exercised, shares   39      
Warrants exercised, amount 234 $ 0 234 0 0
Conversion of convertible notes to common stock, shares   20      
Conversion of convertible notes to common stock, amount 208 $ 0 208 0 0
Balance, shares at Mar. 31, 2026   876      
Balance, amount at Mar. 31, 2026 $ 6,672 $ 1 $ 72,890 $ (65,973) $ (246)